120 related articles for article (PubMed ID: 10050790)
1. Differential expression of cyclin D1 in breast papillary carcinomas and benign papillomas: an immunohistochemical study.
Saddik M; Lai R; Medeiros LJ; McCourty A; Brynes RK
Arch Pathol Lab Med; 1999 Feb; 123(2):152-6. PubMed ID: 10050790
[TBL] [Abstract][Full Text] [Related]
2. An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas.
Wang Y; Zhu JF; Liu YY; Han GP
Diagn Pathol; 2013 Jan; 8():8. PubMed ID: 23327593
[TBL] [Abstract][Full Text] [Related]
3. Papillomatous breast lesions with atypical columnar cell features.
de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast.
Loh SF; Cooper C; Selinger CI; Barnes EH; Chan C; Carmalt H; West R; Gluch L; Beith JM; Caldon CE; O'Toole S
J Clin Pathol; 2015 Mar; 68(3):187-91. PubMed ID: 25501285
[TBL] [Abstract][Full Text] [Related]
5. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.
Saddik M; Lai R
J Clin Pathol; 1999 Nov; 52(11):862-4. PubMed ID: 10690183
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
7. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
[TBL] [Abstract][Full Text] [Related]
8. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
9. Papilloma and papillary carcinoma.
Koerner F
Semin Diagn Pathol; 2010 Feb; 27(1):13-30. PubMed ID: 20306827
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
[TBL] [Abstract][Full Text] [Related]
11. Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5/p63/cytokeratin 8/18 antibody cocktail in their distinction.
Reisenbichler ES; Balmer NN; Adams AL; Pfeifer JD; Hameed O
Mod Pathol; 2011 Feb; 24(2):185-93. PubMed ID: 21076459
[TBL] [Abstract][Full Text] [Related]
12. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.
Timler D; Tazbir J; Matejkowska M; Gosek A; Czyz W; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():201-2. PubMed ID: 11820608
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
Papotti M; Eusebi V; Gugliotta P; Bussolati G
Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
16. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.
Tse GM; Tan PH; Ma TK; Gilks CB; Poon CS; Law BK
J Clin Pathol; 2005 Nov; 58(11):1185-8. PubMed ID: 16254109
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
[TBL] [Abstract][Full Text] [Related]
19. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note.
Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Nomura Y; Takenaka M; Naito Y; Akiba J; Yano H
J Clin Pathol; 2014 Mar; 67(3):258-62. PubMed ID: 24062357
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
